A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT06692764
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 202 participants
- Sponsor
- Registry
-
NCT06692764
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06692764. Randomized; triple masking; primary purpose treatment. Start 2024-10-30 (actual); primary completion 2025-04-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
- Acronym
- AZD0780-ABPM
- Condition
- Atherosclerotic Cardiovascular Disease
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- AZD0780
- Lead sponsor
- AstraZeneca
- Collaborator
- Fortrea
Record details
- Record id
cardio:ct-nct06692764- Content hash
5294e37b02c8eb7b98d8219976a292d06da5e97fbd0a88ee0c7b18126c0658b2